MALVERN, Pa.--(BUSINESS WIRE)--Progenra, Inc. (“Progenra”) announced today that it has entered into a research collaboration with Ono Pharmaceutical Co., Ltd (“Ono”). Under the agreement, Progenra will collaborate with Ono to conduct assay development and high throughput screening by using Progenra’s proprietary technology on multiple targets in the ubiquitin pathway. Terms of the agreement were not disclosed.
